Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT05748821 |
| Other study ID # |
194 |
| Secondary ID |
|
| Status |
Recruiting |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
April 1, 2023 |
| Est. completion date |
December 20, 2023 |
Study information
| Verified date |
July 2023 |
| Source |
Salisbury University |
| Contact |
Tim Werner, PhD |
| Phone |
410-548-3526 |
| Email |
tjwerner[@]salisbury.edu |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
The purpose of this study is to investigate the acute effects of autoregulated (AR) and
non-autoregulated (NAR) blood flow restriction (BFR) bicep curls on indices of arterial
stiffness. We are attempting to differentiate physiological changes with AR and NAR bicep
curl exercise. Twenty adults aged 18-40 years old will undergo three treatment sessions
(control (no BFR), AR BFR and NAR BFR) in a randomized order separated by one week. A
familiarization session will also occur one week before starting the treatment period. Each
subject will undergo a series of tests including anthropometry, ultrasonography of the
carotid artery, applanation tonometry, ultrasonography of the vastus lateralis, blood
pressure acquisition, body composition, and maximal strength assessments (1RM). After a
familiarization session with the BFR device, subjects will perform arm curls during the three
treatment sessions with 4 sets to failure with a 2 seconds concentric and 2 seconds eccentric
cadence, at 20% 1RM using 60% of the supine limb occlusion pressure (LOP) with 1-minute rest
intervals. Assessments will be performed immediately before and after the exercise bout
during each treatment session. Two-way ANOVAs will be used to examine the effects of
treatment and the treatment-order interaction on pulse wave velocity, beta-stiffness index,
and augmentation index.
Description:
Visit 1: Familiarization session. Resting BP; urine sample (female participants only);
carotid artery ultrasonography, applanation tonometry anthropometric measurements; body
composition measurement; arm curl 1 RM (Appendix 1), familiarization of arm curl exercise
with BFR device which includes performing four sets with repetitions (rep) of 30, 15, 15, and
15 at 20% of 1RM with 1 minute of rest between sets.
Visit 2 - 4: Treatment session. Carotid artery ultrasonography, applanation tonometry, and
vastus lateralis ultrasonography before and immediately after arm curl exercise. Arm curl
exercise with randomized no-BFR or BFR device (auto- or nonautoregulated) will be set at 60%
of LOP in supine position) and will include four sets to failure at 20% of 1RM with 2 seconds
concentric and 2 seconds eccentric movements per repetition and 1 minute of rest between
sets. Cadence will be maintained with an electronic metronome.
The familiarization and treatment sessions will be separated by 1-week.
Devices and Measurements Pregnancy Test. This procedure requires collection of 2-3 teaspoons
of urine from all female subjects in a testing cup. Indicator strips (Sekisui Diagnostics
OSOM hCG Urine Test Kit, 100% specificity and sensitivity) will be used to test for
pregnancy. The P.I. will instruct the participant on the procedure for urine collection. The
collection will be completed in a bathroom in Devilbiss Hall. The participant will be
instructed to wipe the outer urethra with Castile Soap Towelettes before urinating into a
disposable urine collection cup. She will fill the cup with urine, replace the lid and place
the cup on a shelf in the bathroom. If the subject is pregnant or the test indicates a
current pregnancy, the participant will be immediately notified and will not be able to
participate in this study. The participant will be recommended to visit Salisbury
University's Student Health Center located in Holloway Hall, room 180 (for SU students) or
Wicomico County's Health Department located on 108 E. Main Street in downtown Salisbury, MD
for additional support and guidance. The medical waste will be disposed of properly in the
Biohazard container inside Devilbiss Hall 316. Spills will be collected with absorptive,
disposable towels and surface will be wiped clean with Clorox Wipes. The PI will conduct all
the pregnancy tests and the results will be kept confidential.
Autoregulated (AR) and non-autoregulated (NAR) BFR training devices. AR and NAR BFR training
devices (Delfi, Vancouver, Canada) will be used for all exercise and testing sessions
(Appendix 2). Cuffs will be placed around the right and left proximal arm. The LOP will be
set at 60% immediately before exercise and will be applied during the entire exercise set
(approximately 30-60 seconds in duration). The AR BFR training device will maintain 60% of
the LOP during the entire range of motion. Its diameter will increase during the concentric
phase to accommodate the muscle enlargement and decrease during the eccentric phase to
accommodate muscle reduction. The NAR BFR training device will also have the LOP set at 60%
but the tension will not be constant during the entire range of motion. This is because the
diameter of the cuff will not change during the concentric and eccentric phases, causing
greater pressures to occur in the thigh during the concentric phase. The LOP will be
decreased to 0% immediately after the set is completed.
β Stiffness Index. β stiffness index will be the primary outcome in the present study. In
contrast to other indices, β stiffness index is a blood pressure independent index of central
arterial stiffness. High resolution ultrasound (Terason uSmart 3300, Burlington, MA) will be
used to measured common carotid artery diameters (see below) and applanation tonometry will
be used to measure carotid blood pressure (see below). β stiffness index will then be
calculated as: β=(log P1/P0) / ((D1-D0)/D0), where D0 is the smallest diameter, D1 is the
maximal diameter, P0 is the lowest pressure, and P1 is the maximal pressure; the β index is
expressed in arbitrary units. Carotid Artery Ultrasonography. Common carotid artery diameters
will be measured from the longitudinal B-mode images derived from an ultrasound unit (Terason
uSmart 3300, Burlington, MA) equipped with a high resolution linear array transducer. The
transducer will be wiped cleaned of the electrode gel with a cloth rag after every recording.
All tonometry recordings will be taken by the same experienced researcher (TW) with excellent
reproducibility (r>0.90; p<0.05) for β-stiff. In the event of an aberrant finding such as a
clot, plaque development, etc., the participant will be given a digital copy of the
ultrasound scan and will be referred to follow-up with their primary care provider. For all
female participants- a female researcher/faculty member will be in the room during this
assessment.
Arterial Applanation Tonometry. The carotid arterial pressure waveform and amplitude will be
obtained from the common carotid artery with a probe incorporating a high-fidelity strain
gauge transducer (Complior Analytic Tonometer, Alam Medical, Vincennes, France). The pressure
signal obtained by tonometry will be calibrated by equating the carotid mean arterial
pressure to the brachial artery measurement via mercury sphygmomanometry. The tonometer will
be cleaned with an alcohol swab after every recording. All tonometry recordings will be taken
by the same experienced researcher (TW) with excellent reproducibility (r>0.90; p<0.05) for
carotid waveforms. For all female participants- a female researcher/faculty member will be in
the room during this assessment.
Pulse Wave Velocity. Non-invasive pulse tonometers (Complior Analytic Tonometer, Alam
Medical, Vincennes, France) will be used to simultaneously obtain arterial pressure waveforms
at the carotid, brachial, radial and femoral arteries throughout ten cardiac cycles. Surface
distance between the two recording sites will be measured to the nearest 0.5 cm.
Subsequently, this process is repeated to measure arterial pressure waveforms at the carotid
and radial arteries. Pulse wave velocity for the carotid-femoral (aortic PWV) and
carotid-radial (brachial PWV) recordings will be determined by normalizing the waveform
foot-to-foot time delay to the distance between recording sites (i.e., PWV = D (cm)/Δt
(sec)). The participant will remain supine exactly as they were positioned during the
tonometry acquisition sequence. An enlarged caliper will be used to measure the distance
between the carotid and radial tonometer, and the distance between the carotid and femoral
tonometer. The caliper will be cleansed with disinfected wipes and stored in the lab for
research use only after the testing session. All tonometry recordings will be taken by the
same experienced researcher (TW) with excellent reproducibility (r>0.90; p<0.05) for pulse
wave velocity (PWV). For all female participants- a female researcher/faculty member will be
in the room during this assessment.
Bicep Brachii ultrasonography. Participants' muscle cross-sectional area (mCSA) and echo
intensity (EI) of the Bicep Brachii (BB) muscle will be assessed using a brightness mode
(B-mode) of the ultrasound imaging system (Terason t3300, MA, USA) and a multi-frequency
linear-array probe (Model 15L4 Smart Mark 4-15 MHz, 50-mm field of view). All ultrasonic
scans will be conducted on the participants' right arm to measure the mCSA and EI of the BB.
Each participant will be instructed to position on their left side at a elbow angle of 10°.
The BB measurements will be obtained from their right arm at 50% of the distance between the
greater tubercle and lateral epicondyle. Locations of measurements will be marked with
indelible ink to ensure scans will be taken at the same area of the BB muscle. During every
scan, water-soluble gel will be applied on the skin and ultrasound probe to maximize acoustic
coupling and reduce near-field artifacts. To limit compression of the muscle, the probe will
be carefully placed on the skin surface and consistent minimal pressure will be applied. The
system setting for image gain will be set at 50 decibels (dB), the dynamic range will be set
at 72 dB, and the image depth will be set at a range of 2 to 4 cm based on the tissue
thickness of each participant's thigh. All ultrasound scans will be taken by Dr. Moghaddam,
an experienced individual with appropriate intra-class correlation coefficient (ICC) and
standard error of the measurement (SEM) for both mCSA (ICC = 0.97, SEM = 1.02 cm2) and EI
(ICC = 0.98, SEM = 1.02 au).
Limb occlusion pressure (LOP). LOP will be determined using the gold standard method. A cuff
will be placed around the proximal right and left arm. The device (Delfi, Vancouver, Canada)
will assess the LOP by measuring the systolic blood pressure, very similar to automated blood
pressure acquisition, in both the right and left arms at the same time. Measurements will be
discontinued if the participant request the cuff be deflated before obtaining the LOP.
Dr. Werner will be performing the LOP assessments.
Body Mass and Composition. Body Mass and composition will be measured in DH 325. Body weight
will be measured on a digital scale accurate to +0.1 kg. between 7 a.m. and 12p.m. and will
be weighed prior to breakfast and after attempting to void. Participants will wear a swim
cap, standard shorts and t-shirt at the time of weighing. Female participants are allowed to
wear a sports bra for this assessment, but are not required. Body height will be measured
with a stadiometer. Total fat and fat-free mass will be measured in all subjects using the
BODPOD (Cosmed Metabolic Company, Chicago, IL) . This system utilizes air displacement
plethymograph to assess whole-body densitometry. The test requires the subject to sit quietly
in the "egg-shape" container as the machine samples air pressure and volume within the
chamber. A total of three readings are required before an average density score is
calculated. The testing time is approximately five minutes. The BODPOD will be cleansed with
disinfected wipes and after every testing session. All participants will be instructed to
press the "stop test" green button under their left leg inside the unit if they experience
claustrophobia or any other event that would preclude them from finishing the assessment.
Drs. Marquette or Werner will be perform the BODPOD assessments. Both have experience with
this measurement, teaching the compentencies to students and using the technology in
previously approved Salisbury University IRB studies.
Resting BP. These measurements will be performed in the Exercise Physiology Research Lab
between 7:00 am and 12:00 pm; serial measurements on subjects will be performed at the same
time each visit. Subjects will not have eaten or ingested caffeine-containing beverages prior
to reporting to the laboratory. The recordings will be made under quiet, comfortable ambient
(~24 degree Celsius) laboratory conditions. All BP measurements will conform strictly to
American Heart Association guidelines. Briefly, measurements will be made by auscultation
over the brachial artery using an automated sphygmomanometer (Welch Allyn, Chicago, IL). The
first and fifth phase of the Karotkoff sounds will be used to determine systolic and
diastolic BP, respectively. At least 3 measurements will be taken in the upright sitting
position. Repeated measurements will be obtained until systolic and diastolic BP are within 6
mmHg on consecutive visits. The sphygmomanometer will be cleansed with disinfected wipes and
stored in the lab for research use only after every testing session. Dr. Werner will be
performing all BP assessments.
The PI, Co-PIs, and student investigators involved with subject testing will comply with all
SU COVID-related requirements. They will all be fully vaccinated per SU COVID-related
protocols. They will be tested by the SU-sponsored COVID testing center. The investigators
and participants are recommended to use personal protection equipment (i.e., face mask)
during the visits. If the PI would test positive, he will no longer conduct the in-person
testing sessions until cleared by the university. If the participants would become
symptomatic, they will not be allowed to participate in the study until cleared by the
university. The investigators will use personal protective equipment (i.e., face mask,
gloves, gown) during the testing sessions. The research team will strive maintaining 6-feet
and more distance from the participant during testing to the best of their ability. Dr.
Rolnick is only involved in the study design and manuscript development, and will have any
physical interaction with any of the subjects or other research team members, thus will not
be subjugated to SU-COVID-related standards. Only one participant will be scheduled at a time
for each in-person testing session (i.e., visits 1- 4). Before and after each scheduled
testing, the equipment and the surface area of the labs will be cleaned and disinfected by
bleach and alcohol (at least 70% alcohol) wipes. The researchers will arrange for SU
housekeeping to deep clean the research site in between scheduled testing days. All wipes,
supplies, and medical wastes will be properly disposed in the Biohazard container in the lab.
The research team will practice social distancing and safety protocols during the testing
sessions. If the university would mandate shutting down research studies and laboratories,
the research team will follow the SU policies and procedures and stop the data collection
